Literature DB >> 19729260

Two-dimensional LC-MS/MS determination of antiretroviral drugs in rat serum and urine.

R Nageswara Rao1, Dhananjay D Shinde.   

Abstract

A simple, rapid, reliable and highly sensitive on-line two-dimensional reversed-phase liquid chromatography-tandem mass spectrometric (2D-LC/MS/MS) method to determine antiretroviral drugs viz., abacavir (ABC), nevirapine (NVP) and indinavir (IDV) in rat serum and urine was developed and validated. The analytes were extracted on-line from rat serum and urine by a restricted access material (RAM) column and back-flushed into the reversed-phase C18 column for separation by LC. Detection was carried out by ESI-MS/MS. The developed method showed good selectivity, accuracy and precision for quantification of the antiretroviral drugs in rat serum and urine. Quantification limits for abacavir and nevirapine were 4.0 ng ml(-1), whereas for indinavir 4.7 ng ml(-1). The calibration graphs were linear in the range of 4-50 ng ml(-1)for abacavir, nevirapine and indinavir. The method was successfully applied to study the pharmacokinetics of antiretroviral in rats.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729260     DOI: 10.1016/j.jpba.2009.07.005

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  2 in total

1.  Targeted quantification of lipid mediators in skeletal muscles using restricted access media-based trap-and-elute liquid chromatography-mass spectrometry.

Authors:  Zhiying Wang; Liangqiao Bian; Chenglin Mo; Maciej Kukula; Kevin A Schug; Marco Brotto
Journal:  Anal Chim Acta       Date:  2017-07-14       Impact factor: 6.558

2.  Molecular recognition of the antiretroviral drug abacavir: towards the development of a novel carbazole-based fluorosensor.

Authors:  Krzysztof Ryszard Idzik; Piotr J Cywinski; Charles G Cranfield; Gerhard J Mohr; Rainer Beckert
Journal:  J Fluoresc       Date:  2011-01-11       Impact factor: 2.217

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.